HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 102 filers reported holding HERON THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,370,656 | -13.9% | 8,126,849 | -3.0% | 0.00% | – |
Q2 2023 | $9,716,820 | -31.6% | 8,376,568 | -10.9% | 0.00% | – |
Q1 2023 | $14,195,634 | -41.2% | 9,401,084 | -2.6% | 0.00% | -100.0% |
Q4 2022 | $24,126,777 | -38.2% | 9,650,709 | +4.2% | 0.00% | 0.0% |
Q3 2022 | $39,071,000 | +59.2% | 9,258,303 | +5.3% | 0.00% | 0.0% |
Q2 2022 | $24,540,000 | -47.4% | 8,795,900 | +7.8% | 0.00% | 0.0% |
Q1 2022 | $46,650,000 | -33.5% | 8,156,131 | +6.2% | 0.00% | -50.0% |
Q4 2021 | $70,139,000 | -14.5% | 7,682,201 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $82,023,000 | -29.7% | 7,672,868 | +2.0% | 0.00% | -33.3% |
Q2 2021 | $116,740,000 | +0.9% | 7,521,849 | +5.4% | 0.00% | 0.0% |
Q1 2021 | $115,697,000 | -20.6% | 7,137,310 | +3.6% | 0.00% | -40.0% |
Q4 2020 | $145,763,000 | +68.8% | 6,886,932 | +18.2% | 0.01% | +66.7% |
Q3 2020 | $86,346,000 | -7.1% | 5,826,318 | -7.8% | 0.00% | -25.0% |
Q2 2020 | $92,931,000 | +40.1% | 6,317,554 | +11.8% | 0.00% | +33.3% |
Q1 2020 | $66,334,000 | -51.1% | 5,650,176 | -2.0% | 0.00% | -40.0% |
Q4 2019 | $135,552,000 | +44.4% | 5,768,202 | +13.7% | 0.01% | +25.0% |
Q3 2019 | $93,883,000 | +3.0% | 5,074,686 | +3.5% | 0.00% | 0.0% |
Q2 2019 | $91,116,000 | -23.3% | 4,901,392 | +0.9% | 0.00% | -20.0% |
Q1 2019 | $118,747,000 | -6.8% | 4,858,735 | -1.1% | 0.01% | -16.7% |
Q4 2018 | $127,443,000 | -15.8% | 4,913,006 | +2.8% | 0.01% | -14.3% |
Q3 2018 | $151,313,000 | -14.3% | 4,780,799 | +5.2% | 0.01% | -12.5% |
Q2 2018 | $176,563,000 | +82.1% | 4,544,731 | +29.4% | 0.01% | +60.0% |
Q1 2018 | $96,952,000 | +79.9% | 3,512,721 | +18.0% | 0.01% | +66.7% |
Q4 2017 | $53,891,000 | +15.6% | 2,977,436 | +3.2% | 0.00% | +50.0% |
Q3 2017 | $46,615,000 | +20.4% | 2,886,424 | +3.2% | 0.00% | 0.0% |
Q2 2017 | $38,732,000 | -2.7% | 2,796,551 | +5.3% | 0.00% | 0.0% |
Q1 2017 | $39,823,000 | +107529.7% | 2,654,845 | +93479.3% | 0.00% | – |
Q4 2016 | $37,000 | -40.3% | 2,837 | -21.8% | 0.00% | – |
Q3 2016 | $62,000 | -16.2% | 3,626 | -11.6% | 0.00% | – |
Q2 2016 | $74,000 | +80.5% | 4,104 | +94.2% | 0.00% | – |
Q1 2016 | $41,000 | +105.0% | 2,113 | +176.2% | 0.00% | – |
Q4 2015 | $20,000 | -23.1% | 765 | -27.4% | 0.00% | – |
Q3 2015 | $26,000 | +52.9% | 1,054 | +90.3% | 0.00% | – |
Q2 2015 | $17,000 | +112.5% | 554 | 0.0% | 0.00% | – |
Q1 2015 | $8,000 | +33.3% | 554 | 0.0% | 0.00% | – |
Q4 2014 | $6,000 | +20.0% | 554 | 0.0% | 0.00% | – |
Q3 2014 | $5,000 | -28.6% | 554 | 0.0% | 0.00% | – |
Q2 2014 | $7,000 | – | 554 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |